Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
John Ostrominski
FINE-HEART Pooled Analysis
Maria Pabon
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Akshay S. Desai, MD
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Jonathan Cunningham, MD
Treating ATTR-CM: Current Strategies and Emerging Options
Frederick Ruberg, MD
Understanding the Pathophysiology Behind ATTR-CM
ATTR-CM Screening: How Economic Factors Can Impact Care
Kibum Kim, PhD
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
Renato D. Lopes, MD, MHS, PhD
Valeria Caso, MD, PhD
Trade off: Ischemic/Thrombotic vs Bleeding
Elevating Care for Patients With Severe Renal Disease in AAV
Silke R. Brix, MD, MRCP, SCPR
Andreas Kronbichler, MD
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Bernhard Hellmich, MD
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Alexander T. Cohen, MD, MBBS
Patient Case Study: Obesity
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.